Immune cells are exposed to low oxygen tensions as they develop and migrate between blood and different tissues, but the mechanisms by which lymphocytes adapt to hypoxia are poorly understood. Studies reported here of hypoxia-inducible factor 1␣ (HIF-1␣) in lymphocyte development and functions suggest that it has a critical role in regulation of these processes. HIF-1␣ deficiency in Hif1␣ ؊/؊ 3 Rag2 ؊/؊ chimeric mice results in dramatic and cell lineage-specific defects, which include appearance of abnormal peritoneal B-1-like lymphocytes, with high expression of B220 (CD45) receptor-associated protein tyrosine phosphatase and autoimmunity (accumulation of anti-dsDNA antibodies and rheumatoid factor in serum, deposits of IgG and IgM in kidney and proteinuria) as well as distortions of maturation of B-2 lymphocytes in bone marrow.
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I
mmune cells are exposed to low oxygen tensions as they develop and migrate between blood and different tissues (1, 2), but the mechanisms by which lymphocytes adapt to hypoxia are poorly understood. Proliferating lymphocytes use ATP derived from glycolysis (3), and hypoxia-inducible factor 1 (HIF-1) mediates transcriptional activation of the genes encoding glucose transporters and glycolytic enzymes (4, 5) , leading us to investigate the role of HIF-1 in lymphoid development. HIF-1 consists of a constitutively expressed HIF-1␤ subunit and a hypoxia and growth factor-induced HIF-1␣ subunit (4-7). HIF-1␣-deficient (Hif1␣ Ϫ/Ϫ ) mouse embryos die at midgestation (5, (8) (9) (10) , which precludes analysis of later developmental events.
To test whether HIF-1␣ plays a role in the development and functioning of the mouse immune system in vivo, we used the RAG-2-deficient blastocyst complementation system (11) , which allowed us to bypass embryonic lethality and analyze the effect of HIF-1␣ deficiency in T and B lymphocytes. The injection of pluripotent embryonic stem (ES) cells with a homozygous disruption of the gene encoding HIF-1␣ (Hif1␣ 
) ES cells with normal HIF-1␣ expression (12) into Rag2
Ϫ/Ϫ C57BL͞6 (B6) or normal B6 blastocysts resulted in the development of chimeric mice in which lymphocytes were derived from the injected ES cells. The analysis of these chimeric mice reported here revealed that deficiency in HIF-1␣ results in dramatic defects in development of B lymphocytes and in autoimmunity.
Materials and Methods
Mice. Mouse studies were performed in accordance with institutional guidelines of the National Institute of Allergy and Infectious Diseases, National Institutes of Health. Control wildtype mice and C57BL͞6 (B6) mice, with or without RAG-2 deficiency as a source of blastocysts, were purchased from Taconic Farms and maintained at the National Institutes of Health animal facility. Chimeric mice were obtained by injecting ES cells into blastocysts of B6 background Rag2
wild-type mice as described (11) . ES cells with homozygous disruption of HIF-1␣ genes were generated as previously described (12) .
Flow Cytometry. Single-cell suspensions were prepared, and cells were stained with fluorescein isothiocyanate (FITC), phycoerythrin, CyChrome, and allophycocianin-labeled Ab or in combination with biotinylated Ab and dye-conjugated streptavidin (PharMingen) followed by analysis of duplicates or triplicates on a FACScalibur by using CELLQUEST software (Becton Dickinson). All mAbs used for flow cytometry in this study were purchased from PharMingen.
Antibody Titration. Total serum IgM and IgG were measured by using Mouse Ig ELISA quantitation kits (Bethyl Laboratories, Montgomery, TX) and ELISA starter accessory package (Bethyl Laboratories) according to manufacturer's instructions. The titers of anti-dsDNA Ab in mouse serum were determined by using 0.001% of protamine sulfate (Sigma) and the calf thymus DNA (Sigma) coated ELISA plates. Horseradish peroxidaseconjugated goat anti-mouse IgM (Caltag, South San Francisco, CA) and goat anti-mouse IgG (ICN) were used for detection of anti-dsDNA IgM and IgG, respectively. The titers of rheumatoid factors (RF) in serum were analyzed by using goat IgG precoated ELISA plates. IgM-RF and IgG-RF were detected by using horseradish peroxidase-conjugated anti-mouse IgM and antimouse IgG, respectively. The titers of anti-dsDNA Ab and RF are determined as absorbance at 450 nm wavelength.
Immunohistochemistry. The visualization of IgM and IgG on paraffin-embedded sections of kidney was performed by using biotin-labeled anti-IgM and anti-IgG mAb and fuchsiaconjugated streptavidin reagents (Dako).
Measurement of Protein Levels in Urine.
The protein concentration in urine samples from mice was determined by using a Microprotein kit (Sigma).
Results
The HIF-1␣-deficient chimeric mice had short limbs (data not shown) and were found to have ES cell-derived lymphocytes as defined by the Ly-9.1 allelic marker. Analysis of the gated Ly-9. The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
cell subsets in the thymus (Fig. 1 A and B) , spleen ( Fig. 1 C and  D) , lymph nodes and peripheral blood of chimeric mice (data not shown), and dramatic distortions in phenotype of B cells ( Fig. 2 ; see also Figs. 4 and 5) .
Studies of defects in bone structure are in progress, but in the first series of experiments, we focused on investigations of changes in well described surface markers of B lymphocytes (13) (14) (15) (16) (17) . Analysis of peritoneal lymphocytes in Hif1␣ Ϫ/Ϫ 3 Rag2 Ϫ/Ϫ chimeric mice revealed dramatic changes in expression of B1 cell-defining CD5 and B220 surface markers (Fig. 2) , whereas no differences were found in levels of expression of CD5 and B220 between control Hif1␣ ϩ/ϩ ES 3 Rag2 Ϫ/Ϫ chimeric mice and normal B6 or 129 mice (data not shown). The CD5 dull B220 Ϫ/dull subset that was observed in Hif1␣ ϩ/ϩ chimeras ( Fig. 2 A) was lost, whereas accumulation of unusual CD5 ϩ ͞ B220 ϩ cells was detected in Hif1␣ and Hif1a ϩ/ϩ chimeric mice (A, C-E, and O) or with age-matched wild-type 129 mice (I-K and P). Cells were gated according to forward vs. side scatter, and then ES cell-derived Ly-9.1 ϩ cells were gated to be further analyzed for staining with mAb to various surface markers (13) (14) (15) (16) (17) . Single-cell suspensions of peritoneal cavity cells were stained and analyzed by flow cytometry. The assays were done in triplicates or duplicates. The results are representative outcomes from studies of three generations of independently derived chimeric mice. Peritoneal cavity cells of control wild-type (WT Hif1a ϩ/ϩ ES 3 RAG-2 Ϫ/Ϫ ) chimera (A) and from Hif1a Ϫ/Ϫ ES 3 RAG-2 Ϫ/Ϫ chimera (B) were harvested and stained with anti-Ly-9.1 mAb, anti-CD5 mAb, and anti-B220 mAb. Then, ES-derived Ly-9.1 ϩ cells were analyzed for expression of both CD5 and B220 by flow cytometry. This was followed by analysis of different CD5͞B220-defined cell populations for expression of such B-1 cell markers like IgM vs. IgD (C-H, O, and Q) and Mac-1 vs. CD23 (I-N, P, and R). Demonstration of typical IgM high and IgD low peritoneal B-1 and B-1-like cells in wild-type (WT) and HIF-1␣-deficient chimeras was accomplished by gating for analysis B220 negative-dull ͞CD5 dull fraction (C and F), B220 ϩ ͞CD5 ϩ fraction (D and G), and B220 ϩ ͞CD5 Ϫ fraction (E and H). IgM͞IgD expression on total peritoneal cavity cells are depicted in O (WT chimera) and in Q (Hif1a Ϫ/Ϫ 3 RAG-2 Ϫ/Ϫ chimera). Proportions of cells are indicated in each panel. The presence of typical B1 cells among B220 negative-dull ͞CD5 dull fraction of peritoneal cells from WT mouse and among B220 ϩ ͞CD5 ϩ fraction of Hif1a chimeras was confirmed in studies of Mac-1 (CD11b) vs. CD23 expression on peritoneal cells collected from 129 mouse (I-K) and from Hif1a Ϫ/Ϫ 3 RAG-2 Ϫ/Ϫ chimera (L-N). In this experiment, cells were analyzed for the expression levels of Mac-1 and CD23 after cells were stained with anti-CD5 mAb, anti-B220 mAb, anti-Mac-1 mAb, and anti-CD23 mAb. B220 negative-dull CD5 dull fraction (I and L), B220 ϩ ͞CD5 ϩ fraction (J and M), and B220 ϩ ͞CD5 Ϫ fraction (K and N) were gated for analysis. Expression of Mac-1 and CD23 on total peritoneal cavity cells is depicted in P (WT mouse) and in R (Hif1a Ϫ/Ϫ 3 RAG-2 Ϫ/Ϫ chimera). It was confirmed in control experiments that profiles of CD5͞B220 expression on Ly-9.1 ϩ cells and Ly-9.1 ϩ ͞Ly-9.1 Ϫ cells in Hif1a Ϫ/Ϫ ES 3 RAG-2 Ϫ/Ϫ chimera were similar. This allowed the comparison of cells in C-R without gating for Ly-9.1 expression. (Fig. 2 J and M) and of CD5 Ϫ B220 ϩ B-1 cells (Fig. 2 K and N) . The increase in cells with abnormal B-1 phenotype was accompanied by a corresponding decrease in proportions of other cells (e.g. Mac-1 Ϫ ͞CD23 ϩ , from 84% to 40%) in the peritoneum of Hifl␣ Ϫ/Ϫ mice ( Fig. 2 K and N) . Thus, whereas the total numbers of cells harvested from the peritoneum of control and HIF-1␣-deficient mice are similar (data not shown), the proportion of IgM high ͞IgD low ( Fig. 2 O and Q) and Mac-1 ϩ ͞CD23 Ϫ (Fig. 2 P and R) cells with B-1 phenotype is much larger in Hif1␣ Ϫ/Ϫ chimeras.
B-1 cells were reported to play a role in autoimmunity (16) , and this prompted us to investigate the possibility of autoimmunity in Hif1␣ Ϫ/Ϫ chimeras with abnormal B-1-like cells. Subsequent studies of 6-8-week-old mice revealed markedly increased levels of both IgM and IgG anti-dsDNA autoantibodies ( Fig. 3 C and D) in the serum of the Hif1␣ Ϫ/Ϫ chimeras. Total IgM levels were also increased in the serum of Hif1␣ Ϫ/Ϫ chimeras, whereas no difference in IgG levels was found ( Fig. 3 A and  B) . This was accompanied by extensive deposits of IgM and IgG in kidneys of Hif1␣ Ϫ/Ϫ , but not Hif1␣
, chimeras (Fig. 3 E-H) . Evidence of autoimmune disease was also provided by the demonstration of proteinuria (Fig. 3I ) and accumulation of RF (Fig. 3 J-L) in Hif1␣ Ϫ/Ϫ chimeras. Taken together, these observations suggest that HIF-1␣ is important for proper regulation of B1 cell homeostasis and that HIF-1␣ deficiency results in autoimmunity.
Deficiency in HIF-1␣ also results in age-dependent defects in the subset composition of immature and mature conventional B-lymphocytes (B-2 cells) in bone marrow as reflected by the absence of IgM high and B220 high (immature) population after 8 weeks of age (Fig. 4 D-G) and appearance of B220 high cells after 12 weeks (Fig. 4 H-K) .
Studies of B-2 cells allowed us to discriminate between cell-autonomous and noncell autonomous effects of HIF-1␣ deficiency [e.g., because of the defects in HIF-1␣-dependent angiogenesis and organogenesis (4, 7, 8) (Fig. 5B) and results of IgM vs. B220 and CD43 vs. B220 analysis (Fig. 4) suggest that HIF-1␣ may be required for the transition from large preB to small preB [fraction D by Hardy et al. (17) ] to immature B (fraction E) cells.
Further studies revealed that HIF-1␣ deficiency results in the depletion of highly proliferating cells among B cell progenitors in bone marrow, as CD43 Ϫ B220 The titers of rheumatoid factors in serum were determined by using goat IgG precoated ELISA plates. IgM-RF and IgG-RF were detected by using horseradish peroxidase-conjugated antimouse IgM and anti-mouse IgG, respectively. Serum samples were diluted as indicated and were tested (J). Serum samples diluted 100 times were used to compare levels of RF-IgM and RF-IgG in serum samples from seven Hif1a Ϫ/Ϫ 3 Rag2 Ϫ/Ϫ chimeras and six B6 mice (K and L). Six-to eight-week-old mice were used in these series of experiments. (Fig. 5D ).
Discussion
The multiple roles of hypoxia-inducible HIF-1␣ in cell metabolism and functions (4-10) and the predominance of hypoxic conditions in lymphoid tissues in vivo (2) suggested that this protein could be involved in the development and regulation of cells of the immune system. The direct testing of the possible role of HIF-1␣ in the immune system was precluded by midgestation death of HIF-1␣-deficient (Hif1␣ Ϫ/Ϫ ) mouse embryos (5, (8) (9) (10) . The use of the RAG-2-deficient blastocyst complementation system (11) allowed to bypass embryonic lethality and revealed that HIF-l␣ deficiency in Rag-2 Ϫ/Ϫ chimeric mice results in abnormal peritoneal B-1 cells, autoimmunity, and abnormal maturation of B-2 lymphocytes.
The striking cell-lineage specificity of the defects attributable to HIF-1␣ deficiency [no changes in T-cell subsets (Fig. 1) and distortion of B-1 and B-2 cell development] suggests that it is unlikely that these defects are because of nonspecific effects of HIF-1␣ deficiency on cell viability. Rather, they implicate HIF-1␣ in the control of B cell progenitor proliferation, which must occur by different mechanisms in B-1 and B-2 as compared with T cells based on our data. Indeed, proliferation of Hif1␣ Ϫ/Ϫ B cells in vivo is inhibited in Hif1␣ Ϫ/Ϫ mice (Fig. 5D) (Fig. 5D) . These results indicate that HIF-1␣ deficiency may cause defects in proliferation of immature B cells and that the age-dependent distortion of B cell development in bone marrow may reflect the rate of B cell expansion.
The lymphoid phenotype of HIF-1␣ deficiency shares similarities and differences with other knockout mouse models (e.g., Btk, BSAP, and PI3K) (19) (20) (21) , which were shown to play key roles in the development or homeostasis of B1 and B2 cells. Functional interactions between these gene products and HIF-1␣ may account for the overlapping phenotypes. For example, PI3K activity has been shown to control HIF-1␣ expression in prostate cancer cells (22) .
The data presented here add to observations suggesting the importance of B-1 cells whose origin and functions have been the subject of controversy since they were first discovered (23) . Thus, whereas the role of HIF-1 in mediating physiological responses to hypoxia is well established, these results demonstrate that HIF-1 also functions in a cell lineage-specific, cell-autonomous and differentiation stage-specific manner to regulate lymphocyte development and to control autoimmunity. Observations of autoimmunity point to the need for further investigations of the role of HIF-1␣ in controlling cell cycle as well as apoptosis in B-lymphocytes, as apoptosis is implicated in the elimination of autoreactive cells and HIF-1␣ was shown to regulate apoptosiscontrolling molecules (7, 8) , including p53 and NIP3. These data provide genetic evidence for the role of HIF-1␣ in the regulation of cell proliferation in vivo in any system and are in agreement with the implied role of HIF-1␣ as the switch to glycolysis in proliferating lymphocytes. These data are also consistent with the demonstration of a correlation between the expression of HIF-1␣ and Ki-67 in human cancers and trophoblast cells (24, 25) . Recent observations of the role of glucose transporter-1 gene (GLUT-1) in lymphocyte homeostasis (24) further support the importance of HIF-1␣, as GLUT-1 expression is controlled by HIF-1 (4, 7) . Perhaps the most striking cell-surface abnormality revealed in the analysis of peritoneal B-1 cells was the marked elevation of B220 (CD45, a receptor-associated protein tyrosine phosphatase) (Fig. 2B) , which is one of the critical modulators of B cell receptor signaling and B lymphocyte development and activation (25) . The reported data suggest that HIF-1␣ expression in B-1 lymphocytes could be required for down-regulation of CD45 (B220) expression during normal B-1 cell development. Additional studies are necessary to delineate the exact molecular pathways by which HIF-1␣ deficiency results in CD45 overexpression in B-1 cells and the consequences of CD45 overexpression with respect to the pathogenesis of autoimmunity.
Taken together, these observations suggest the need to analyze the possibility of autoimmunity as being the outcome of metabolic defects in immune cells and point to the HIF-1␣ as a promising subject of autoimmunity studies. The future directions of research are also suggested by recent demonstration of selective up-regulation of the alternatively spliced HIF-1␣ mRNA isoform I.1, an immediate early response gene that encodes the HIF-1␣ protein without the first 12 N-terminal amino acids in activated lymphocytes (26) . It remains to be established whether the effects of HIF-1␣ deficiency observed here are because of the requirements in this ''short'' I.1 isoform or in the I.2 isoform, which encodes the ''classical'' HIF-1␣.
